Translate
Alx Oncology Holdings
About
Alx Oncology Holdings (NASDAQ:ALXO) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 17 2026
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
Apr 13 2026
ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer
Feb 27 2026
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Feb 19 2026
ALX Oncology to Present at Upcoming Investor Conferences in Q1 2026
Feb 19 2026
ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026
Financials
Revenue
$0
Market Cap
$257.95 M
EPS
-1.90